A1c Explained: What Your Number Means and What It Should Be

What to read next

• Start here for the blood sugar domain: A1c Explained: What Your Number Means and What It Should Be.
• Build the nutrition foundation: Eating Well Without Overthinking It.
• Understand the cholesterol side of metabolic risk: LDL Cholesterol: What the Number Means and Why It Matters.
• Read the evidence base: The Science Behind Vital8.
• Review the scoring appendix: Vital8 Methods and Scoring System.
• Use the tool: Vital8 Score.

The short answer. Your A1c is a single blood test that reveals your average blood sugar over the past two to three months — a report card no single glucose reading can give. For most people without diabetes, an A1c under about 5.7% is normal, 5.7–6.4% is prediabetes, and 6.5% or higher defines diabetes [1]. But here is the part almost no one tells you: the risk to your heart, kidneys, and brain rises steadily long before you ever cross into "diabetes" [2] — and, surprisingly, driving the number too low with medication can be its own hazard [3]. For a long, healthy life, the goal is not the lowest possible A1c. It is the right one.

This is why "Manage Blood Sugar" is one of the American Heart Association's Life's Essential 8, and it is the number behind the blood sugar domain of your Vital8 score.

The number that remembers what you can't

For most of medical history, checking blood sugar was like taking a single photograph of a moving river. A fasting glucose told you what your sugar was that morning, after that meal, on that day — and nothing more. A person could look perfect at 8 a.m. and spend the rest of the day flooding their bloodstream with sugar, and no one would know.

Then came a quiet piece of chemistry that changed everything. Sugar in the blood doesn't just float by — it sticks. It latches permanently onto the hemoglobin inside your red blood cells, the same protein that carries oxygen. The more sugar in your blood, and the longer it's there, the more hemoglobin gets "glycated," or sugar-coated. Because red blood cells live about three months before being replaced, the fraction of your hemoglobin carrying this sugar coating becomes a running average of your blood sugar over that whole span.

That fraction is your A1c. It cannot be faked by skipping breakfast before the test. It doesn't care what you ate this morning. It is the closest thing medicine has to a memory of how your body has actually been handling sugar for months. That is why it became the number that defines diabetes, guides its treatment, and — as we now understand — quietly predicts the health of your heart and blood vessels years in advance [4].

What your A1c means in glucose terms

A1c is reported as a percentage, which is not intuitive. It converts to an estimated average glucose (eAG) in the units you see on a glucose meter [19]:

A1c	Estimated average glucose
5.0%	~97 mg/dL
5.7%	~117 mg/dL
6.5%	~140 mg/dL
7.0%	~154 mg/dL
8.0%	~183 mg/dL
9.0%	~212 mg/dL

The formula is eAG (mg/dL) = 28.7 × A1c − 46.7.

What sugar actually does to your arteries

To understand why this number matters so much, picture the inside of a blood vessel as a smooth, living, self-repairing surface. Chronically high blood sugar corrodes it.

Excess glucose doesn't just coat hemoglobin — it sticks to proteins throughout the body, forming compounds called advanced glycation end-products. These stiffen tissues, inflame the arterial wall, and make the vessel lining dysfunctional and prone to plaque. High sugar thickens the blood, promotes clotting, and accelerates the same process — atherosclerosis — that cholesterol drives. This is why diabetes is, at its core, a cardiovascular disease. In people with type 2 diabetes, every 1-percentage-point rise in A1c is associated with roughly an 18% higher risk of a major vascular event — heart attack, stroke, or peripheral artery disease [5].

The damage runs on two tracks. The large vessels feed the "macrovascular" complications — heart attack, stroke, and clogged leg arteries. The tiniest vessels take a different kind of hit, producing the "microvascular" complications almost unique to sustained high sugar: damage to the retina (a leading cause of blindness), the kidneys (a leading cause of kidney failure), and the nerves [5]. Blood sugar, more than almost any other risk factor, attacks the body from the largest arteries to the smallest capillaries at once.

The risk starts long before "diabetes"

Here is the finding that should reframe how you read your own result. The lines between "normal," "prediabetes," and "diabetes" are drawn for clinical convenience — but your arteries never read the memo. Risk climbs as a smooth, continuous gradient, not a switch that flips at 6.5%.

In a landmark analysis of non-diabetic adults, higher A1c predicted future heart disease and stroke even at values well below the diabetes threshold [4]. In the UK Biobank, spanning hundreds of thousands of people without established heart or kidney disease, the risk of cardiovascular and kidney disease varied several-fold across the A1c spectrum — and most of the future disease occurred in people whose A1c was in the prediabetes range, not the diabetes range [2]. Strikingly, more than two-thirds of those prediabetic people who went on to develop heart or kidney disease never progressed to diabetes at all [2]. Even subclinical, silent atherosclerosis has been shown to track with A1c levels above roughly 5.4% in people without diabetes [6].

The lesson: prediabetes is not "pre" anything for your arteries. It is early cardiovascular risk, and it is the most valuable window you will ever get to change course.

The ideal A1c for a long life is not the lowest one

Now the counterintuitive part — the part that separates honest health information from the "lower is always better" reflex.

When researchers plot A1c against the risk of dying, they don't get a straight line sloping down. They get a curve shaped like a J or a U: risk is high at both ends and lowest in a band in the middle [7]. Very high A1c is dangerous, as expected. But very low A1c is also associated with higher mortality — partly because aggressive drug treatment can cause dangerous low-blood-sugar episodes, and partly because an unusually low number can be a marker of underlying illness, frailty, or poor nutrition.

Large studies have mapped where that band lies:

• Without diabetes, the lowest mortality clusters around an A1c of roughly 5.0–6.0%, with the bottom of the curve near 5.4%. Risk rises both above this band and, more modestly, below about 5.0% [7][8].
• With diabetes, the optimal range for survival sits higher — roughly 6.0–8.0%, with the nadir near 6.5–7.0%. Both poorly controlled sugar (above ~8–9%) and overly tight control (below ~6.0%) are associated with higher mortality [7][9].

A note on the two different numbers. The diagnostic threshold (5.7%) and the mortality nadir (~5.4%) answer different questions. The 5.7% cutoff marks where the risk of developing diabetes and its complications becomes clinically meaningful enough to act on. The mortality curve describes observed death rates across a population, where very low values often flag illness rather than health. Neither invalidates the other — but it does mean that if you are not diabetic and your A1c is 5.2%, there is nothing to chase.

This is also not a license to let blood sugar run high. The danger of a high A1c is real, common, and far more prevalent than the danger of an over-treated low one. It is a caution against the idea that pushing the number toward "normal" at any cost buys you more life. It doesn't.

The trial that proved "too low" can hurt

This isn't just an observation from population data. It was tested directly.

In the ACCORD trial, more than 10,000 people with type 2 diabetes and high cardiovascular risk were randomly assigned to either intensive treatment targeting an A1c below 6.0% or standard treatment targeting 7.0–7.9%. The intensive arm was stopped early after a median of 3.5 years — because those patients were dying at a higher rate, not a lower one [3].

Two sister trials tested the same idea. ADVANCE found that intensive control reduced kidney complications but produced no significant reduction in major cardiovascular events or death, while more than doubling severe hypoglycemia [20]. VADT likewise found no significant cardiovascular benefit from intensive control, with substantially more severe hypoglycemic episodes [21].

The likely culprits: hypoglycemia (dangerous lows that can trigger heart rhythm problems and falls), weight gain, and the burden of piling on medications — especially in people who already have long-standing diabetes and established artery disease, in whom the damage is harder to reverse [10]. The clear signal is that the benefit of tight control is greatest when started early, in younger people with a long life ahead and few complications, and smallest — sometimes negative — when forced late and hard.

So what should your number be?

Because the right target depends on who you are, every major guideline now individualizes it instead of applying one universal cutoff:

• Most non-pregnant adults with diabetes: an A1c under 7% is a reasonable goal [1].
• Younger people, newly diagnosed, with long life expectancy and no significant heart disease: a tighter goal such as under 6.5% may be worthwhile — if it can be reached safely, without frequent lows [1].
• Older adults, or anyone with advanced complications, limited life expectancy, or a history of severe low-blood-sugar episodes: a more relaxed goal such as under 8% is often safer and just as wise [11][12].
• People without diabetes: there's no "treatment target," but keeping your A1c in the normal range through the way you live is one of the highest-value investments you can make in your future heart, kidneys, and brain [2].

The single most important idea is that the right number is a conversation, not a command — matched to your age, your other conditions, how long you're likely to live, and how much the treatment costs you in side effects and daily burden [1].

What if you only have a fasting glucose?

A1c is not the only way in. Fasting plasma glucose and the oral glucose tolerance test diagnose the same conditions, and the Vital8 score accepts either A1c or fasting glucose [1]:

	Fasting plasma glucose	A1c	2-hour OGTT
Normal	<100 mg/dL	<5.7%	<140 mg/dL
Prediabetes	100-125 mg/dL	5.7-6.4%	140-199 mg/dL
Diabetes	≥126 mg/dL	≥6.5%	≥200 mg/dL

The three tests don't always agree in the same person — one can read in the prediabetes range while another reads normal. A diagnosis generally requires either two abnormal results or one abnormal result with clear symptoms of high blood sugar [1].

Where the number's power ends

In the spirit of not overselling: A1c is powerful, but it is not perfect, and knowing its blind spots makes it more trustworthy, not less.

A1c measures the sugar coating on red blood cells — so anything that changes those cells can distort it. If you have anemia, a hemoglobin variant such as sickle cell trait, are pregnant, or have kidney disease, your A1c can read falsely high or low and may not reflect your true average sugar [1]. In those situations, other tests — direct glucose monitoring or a continuous glucose monitor — do the job better.

And A1c is an average. Two people with an identical A1c can have very different swings between highs and lows, which is why time-in-range from a continuous monitor is increasingly used alongside it. The number is a superb summary. It is not the whole story.

How to move your number with lifestyle

Here is the most empowering fact about A1c: it responds to how you live, often as strongly as it responds to medication.

In the Diabetes Prevention Program, people with prediabetes who adopted a structured lifestyle program — aiming for 7% weight loss and at least 150 minutes of physical activity a week — cut their risk of progressing to diabetes by 58%, outperforming the metformin arm, which lowered risk by 31% [13]. The same levers that lower A1c also lower blood pressure, improve cholesterol, and calm inflammation, and they work whether or not you already have diabetes.

Move your muscles — it works even without weight loss. Physical activity makes your cells more sensitive to insulin, pulling sugar out of the blood. In a meta-analysis of structured exercise programs in type 2 diabetes, structured training was associated with an A1c reduction of roughly 0.67%, rising to about 0.89% when it exceeded 150 minutes per week [14]. Earlier meta-analytic work found a comparable reduction of about 0.66% even when body weight did not change [17] — a change on the order of adding a diabetes medication. Combining aerobic with resistance training tends to help most, and short, frequent movement breaks that interrupt long sitting also blunt sugar spikes [16]. See also Be More Active.

Change the plate — pattern matters more than any single food. No single diet is uniquely magic, but some consistently outperform. In a network meta-analysis comparing nine dietary approaches head to head in type 2 diabetes, the Mediterranean pattern produced the largest A1c reduction, with low-carbohydrate, low-glycemic-index, and Mediterranean patterns all outperforming control diets [15]. The Mediterranean pattern is also the one with randomized evidence of long-term cardiovascular benefit [23]. The practical common thread across all of them: fewer refined carbohydrates, sugary drinks, and processed foods; more vegetables, legumes, whole intact grains, nuts, lean protein, and healthy fats like olive oil. Choose the version you can actually sustain — a diet only lowers A1c while you're following it. See also Eat Better.

Lose a little weight — the first 5% is where the payoff starts. In an analysis of the Look AHEAD trial, weight loss of 5–10% was associated with meaningful improvements in A1c, blood pressure, triglycerides, and HDL, while losses under 5% produced substantially smaller benefit [18]. That threshold makes a modest, sustained loss of 5–7% a realistic and worthwhile first goal. In early type 2 diabetes, larger sustained weight loss can push blood sugar back into the normal range — in the DiRECT trial, an intensive weight-management program achieved diabetes remission in 46% of participants at one year, and remission tracked closely with how much weight was lost [22]. See also Manage Weight.

Don't forget sleep, alcohol, and stress. These are the quieter levers, but poor sleep, heavy alcohol use, and chronic stress all raise blood sugar and undercut the gains from diet and exercise [16]. See also Sleep Health.

Treat diabetes as cardiovascular disease, not just "sugar." Lifestyle is the foundation, not a consolation prize — but if you have diabetes, the modern medications that lower A1c and independently protect the heart and kidneys, such as SGLT-2 inhibitors and GLP-1 receptor agonists, are increasingly first-line for exactly that reason [5][10]. They work best layered on top of the habits above, not instead of them.

Aim for your target, not for zero. Work with your clinician to find the A1c that fits your life stage and health — and resist the instinct that lower must always be better [3].

The number that remembers your last three months is trying to tell you something about your next thirty years. The best time to listen is while it's still whispering — in the normal or prediabetes range — rather than waiting until it has to shout.

Frequently asked questions

What is a good A1c level? For someone without diabetes, under 5.7% is normal. For most people with diabetes, under 7% is a common goal, though a tighter goal (under 6.5%) suits some younger, healthier people and a looser one (under 8%) is safer for many older adults. The best target is individualized with your clinician [1].

What's the difference between A1c and a regular blood-sugar test? A finger-stick or fasting glucose is a snapshot of this moment. A1c is a three-month average, because sugar permanently coats your red blood cells over their lifespan. That's why A1c can't be "fixed" by fasting before the test.

Can I lower my A1c without medication? Often, yes — especially in prediabetes and early diabetes. Regular exercise, cutting refined carbohydrates and sugary drinks, and modest weight loss can lower A1c meaningfully, sometimes back into the normal range [13][14][18].

Is an A1c below 5 too low? In people without diabetes, a very low A1c has been linked to slightly higher mortality — usually as a marker of other illness rather than a cause [7]. In people on diabetes medication, an A1c driven too low raises the risk of dangerous low-blood-sugar episodes [3]. Lowest is not the goal; the right range is.

Does prediabetes really matter if it's not diabetes yet? Yes. Most of the heart and kidney disease linked to blood sugar arises in the prediabetes range, and most people with prediabetes who develop that disease never progress to full diabetes [2]. It's the best window you'll get to change the trajectory.

How often should I check my A1c? For people with diabetes at target, roughly twice a year; more often if treatment changed or control is unstable. For people without diabetes, screening frequency depends on age and risk factors — a conversation for your clinician [1].

Related reading

• Life's Essential 8 — the full framework
• Check your Vital8 score
• LDL Cholesterol: What the Number Means and Why It Matters
• Manage Weight

Educational content only. Not medical advice, and not a substitute for evaluation by a healthcare professional. Discuss your own A1c and treatment targets with your clinician.

References

1. American Diabetes Association Professional Practice Committee. "6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes—2026." Diabetes Care. 2026.

2. Honigberg MC, Zekavat SM, Pirruccello JP, Natarajan P, Vaduganathan M. "Cardiovascular and Kidney Outcomes Across the Glycemic Spectrum: Insights From the UK Biobank." J Am Coll Cardiol. 2021;78(5):453–464. doi:10.1016/j.jacc.2021.05.004

3. Action to Control Cardiovascular Risk in Diabetes Study Group; Gerstein HC, Miller ME, Byington RP, et al. "Effects of Intensive Glucose Lowering in Type 2 Diabetes." N Engl J Med. 2008;358(24):2545–2559. doi:10.1056/NEJMoa0802743

4. Selvin E, Steffes MW, Zhu H, et al. "Glycated Hemoglobin, Diabetes, and Cardiovascular Risk in Nondiabetic Adults." N Engl J Med. 2010;362(9):800–811. doi:10.1056/NEJMoa0908359

5. Joseph JJ, Deedwania P, Acharya T, et al. "Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association." Circulation. 2022;145(9):e722–e759. doi:10.1161/CIR.0000000000001040

6. Rossello X, Raposeiras-Roubin S, Oliva B, et al. "Glycated Hemoglobin and Subclinical Atherosclerosis in People Without Diabetes." J Am Coll Cardiol. 2021;77(22):2777–2791. doi:10.1016/j.jacc.2021.03.335

7. Li FR, Zhang XR, Zhong WF, et al. "Glycated Hemoglobin and All-Cause and Cause-Specific Mortality Among Adults With and Without Diabetes." J Clin Endocrinol Metab. 2019;104(8):3345–3354. doi:10.1210/jc.2018-02536

8. Cavero-Redondo I, Peleteiro B, Álvarez-Bueno C, Rodriguez-Artalejo F, Martínez-Vizcaíno V. "Glycated Haemoglobin A1c as a Risk Factor of Cardiovascular Outcomes and All-Cause Mortality in Diabetic and Non-Diabetic Populations: A Systematic Review and Meta-Analysis." BMJ Open. 2017;7(7):e015949. doi:10.1136/bmjopen-2017-015949

9. Wan EYF, Fung CSC, Wong CKH, Chin WY, Lam CLK. "Association of Hemoglobin A1c Levels With Cardiovascular Disease and Mortality in Chinese Patients With Diabetes." J Am Coll Cardiol. 2016;67(4):456–458. doi:10.1016/j.jacc.2015.11.020

10. Marx N, Federici M, Schütt K, et al. "2023 ESC Guidelines for the Management of Cardiovascular Disease in Patients With Diabetes." Eur Heart J. 2023;44(39):4043–4140. doi:10.1093/eurheartj/ehad192

11. Arnold SV, Bhatt DL, Barsness GW, et al. "Clinical Management of Stable Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus: A Scientific Statement From the American Heart Association." Circulation. 2020;141(19):e779–e806. doi:10.1161/CIR.0000000000000766

12. U.S. Department of Veterans Affairs / Department of Defense. "VA/DoD Clinical Practice Guideline for the Management of Type 2 Diabetes Mellitus in Primary Care." 2023.

13. Diabetes Prevention Program Research Group; Knowler WC, Barrett-Connor E, Fowler SE, et al. "Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin." N Engl J Med. 2002;346(6):393–403. doi:10.1056/NEJMoa012512

14. Umpierre D, Ribeiro PAB, Kramer CK, et al. "Physical Activity Advice Only or Structured Exercise Training and Association With HbA1c Levels in Type 2 Diabetes: A Systematic Review and Meta-analysis." JAMA. 2011;305(17):1790–1799. doi:10.1001/jama.2011.576

15. Schwingshackl L, Chaimani A, Hoffmann G, Schwedhelm C, Boeing H. "A Network Meta-analysis on the Comparative Efficacy of Different Dietary Approaches on Glycaemic Control in Patients With Type 2 Diabetes Mellitus." Eur J Epidemiol. 2018;33(2):157–170. doi:10.1007/s10654-017-0352-x

16. American Diabetes Association Professional Practice Committee. "5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes—2026." Diabetes Care. 2026.

17. Boulé NG, Haddad E, Kenny GP, Wells GA, Sigal RJ. "Effects of Exercise on Glycemic Control and Body Mass in Type 2 Diabetes Mellitus: A Meta-analysis of Controlled Clinical Trials." JAMA. 2001;286(10):1218–1227. doi:10.1001/jama.286.10.1218

18. Wing RR, Lang W, Wadden TA, et al. "Benefits of Modest Weight Loss in Improving Cardiovascular Risk Factors in Overweight and Obese Individuals With Type 2 Diabetes." Diabetes Care. 2011;34(7):1481–1486. doi:10.2337/dc10-2415

19. Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ. "Translating the A1C Assay Into Estimated Average Glucose Values." Diabetes Care. 2008;31(8):1473–1478. doi:10.2337/dc08-0545

20. ADVANCE Collaborative Group; Patel A, MacMahon S, Chalmers J, et al. "Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes." N Engl J Med. 2008;358(24):2560–2572. doi:10.1056/NEJMoa0802987

21. Duckworth W, Abraira C, Moritz T, et al. "Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes." N Engl J Med. 2009;360(2):129–139. doi:10.1056/NEJMoa0808431

22. Lean MEJ, Leslie WS, Barnes AC, et al. "Primary Care-Led Weight Management for Remission of Type 2 Diabetes (DiRECT): An Open-Label, Cluster-Randomised Trial." Lancet. 2018;391(10120):541–551. doi:10.1016/S0140-6736(17)33102-1

23. Estruch R, Ros E, Salas-Salvadó J, et al. "Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts." N Engl J Med. 2018;378(25):e34. doi:10.1056/NEJMoa1800389

This guide is part of the MendelMD preventive cardiology library. Explore the related cardiovascular health guides. Vital8 is our broader framework for cardiovascular health.